Nanoparticles labeled with positron emitting nuclides: Advantages, methods, and applications

Bioconjugate Chemistry

Volumn 23, Issue 4, 2012, Pages 671-682

  Liu, Yongjian ^a   Welch, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; ELECTRONS; POSITRONS;

BIOMEDICAL RESEARCH; ENHANCED SENSITIVITY; IN-VIVO; PERSONALIZED MEDICINES; POSITRON EMITTERS; RADIOLABELLING; THERANOSTICS; TRANSLATIONAL RESEARCH; VIVO PHARMACOKINETICS;

NANOPARTICLES;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID CU 64; ALUMINUM HYDROXIDE; ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; BROMINE 76; COPPER 64; DRUG CARRIER; FLUORINE 18; GALLIUM 68; IODINE 124; LATEX; LIPOSOME; MAGNETIC NANOPARTICLE; NANODIAMOND; NANOPARTICLE; NANOTUBE; PENTETATE COPPER CU 64; POLYMER; QUANTUM DOT; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE COPPER CU 64; UNCLASSIFIED DRUG; YTTRIUM 86;

ANGIOGENESIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG BIOAVAILABILITY; DRUG HALF LIFE; ENDOCYTOSIS; HUMAN; LUNG; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUSTAINED DRUG RELEASE;

EID: 84859967416     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200264c     Document Type: Review

References (135)

1. Schober, O., Rahbar, K., and Riemann, B. (2009) Multimodality molecular imaging - from target description to clinical studies. Eur. J. Nucl. Med. Mol. Imaging 36, 302-14.
2. Hagooly, A., Rossin, R., and Welch, M. J. (2008) Small molecule receptors as imaging targets. Handb. Exp. Pharmacol., 93-129.
3. Gunasekera, U. A., Pankhurst, Q. A., and Douek, M. (2009) Imaging applications of nanotechnology in cancer. Target Oncol. 4, 169-81.
4. Sanvicens, N., and Marco, M. P. (2008) Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol. 26, 425-33.
5. Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., and Dai, H. (2007) In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2, 47-52. (Pubitemid 46210038)
6. Villa, C. H., McDevitt, M. R., Escorcia, F. E., Rey, D. A., Bergkvist, M., Batt, C. A., and Scheinberg, D. A. (2008) Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes. Nano Lett. 8, 4221-8.
7. Rojas, S., Gispert, J. D., Martin, R., Abad, S., Menchon, C., Pareto, D., Victor, V. M., Alvaro, M., Garcia, H., and Herance, J. R. (2011) Biodistribution of amino-functionalized diamond nanoparticles. in vivo studies based on (18)F radionuclide emission. ACS Nano 5, 5552-5559.
8. McDevitt, M. R., Chattopadhyay, D., Jaggi, J. S., Finn, R. D., Zanzonico, P. B., Villa, C., Rey, D., Mendenhall, J., Batt, C. A., Njardarson, J. T., and Scheinberg, D. A. (2007) PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PLoS One 2, e907.
9. Khlebtsov, N., and Dykman, L. (2011) Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647-71.
10. Li, S. D., and Huang, L. (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 5, 496-504.
11. Owens, D. E. 3rd, and Peppas, N. A. (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93-102.
12. Cormode, D. P., Skajaa, T., Fayad, Z. A., and Mulder, W. J. (2009) Nanotechnology in medical imaging: probe design and applications. Arterioscler. Thromb. Vasc. Biol. 29, 992-1000.
13. Schipper, M. L., Cheng, Z., Lee, S. W., Bentolila, L. A., Iyer, G., Rao, J., Chen, X., Wu, A. M., Weiss, S., and Gambhir, S. S. (2007) microPET-based biodistribution of quantum dots in living mice. J. Nucl. Med. 48, 1511-8. (Pubitemid 47397401)
14. Zhang, J. S., Liu, F., and Huang, L. (2005) Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv. Drug Delivery Rev. 57, 689-98. (Pubitemid 40332597)
15. Jokerst, J. V., Lobovkina, T., Zare, R. N., and Gambhir, S. S. (2011) Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond.) 6, 715-28.
16. Jarzyna, P. A., Gianella, A., Skajaa, T., Knudsen, G., Deddens, L. H., Cormode, D. P., Fayad, Z. A., and Mulder, W. J. (2010) Multifunctional imaging nanoprobes. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2, 138-50.
17. Welch, M. J., Hawker, C. J., and Wooley, K. L. (2009) The advantages of nanoparticles for PET. J. Nucl. Med. 50, 1743-6.
18. Minchin, R. F., and Martin, D. J. (2010) Nanoparticles for molecular imaging - an overview. Endocrinology 151, 474-81.
19. Loudos, G., Kagadis, G. C., and Psimadas, D. (2010) Current status and future perspectives of in vivo small animal imaging using radiolabeled nanoparticles. Eur. J. Radiol. 78, 287-295.
20. Hong, H., Zhang, Y., Sun, J., and Cai, W. (2009) Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 4, 399-413.
21. Gomes, C. M., Abrunhosa, A. J., Ramos, P., and Pauwels, E. K. (2011) Molecular imaging with SPECT as a tool for drug development. Adv. Drug Delivery Rev. 63, 547-54.
22. Heidel, J. D., and Davis, M. E. (2011) Clinical developments in nanotechnology for cancer therapy. Pharm. Res. 28, 187-99.
23. Schluep, T., Hwang, J., Hildebrandt, I. J., Czernin, J., Choi, C. H., Alabi, C. A., Mack, B. C., and Davis, M. E. (2009) Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements. Proc. Natl. Acad. Sci. U. S. A. 106, 11394-9.
24. Benezra, M., Penate-Medina, O., Zanzonico, P. B., Schaer, D., Ow, H., Burns, A., Destanchina, E., Longo, V., Herz, E., Iyer, S., Wolchok, J., Larson, S. M., Wiesner, U., and Bradbury, M. S. (2011) Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J. Clin. Invest. 121, 2768-80.
25. Ray, P. (2011) The pivotal role of multimodality reporter sensors in drug discovery: from cell based assays to real time molecular imaging. Curr. Pharm. Biotechnol. 12, 539-46.
26. Glaus, C., Rossin, R., Welch, M. J., and Bao, G. (2010) In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjugate Chem. 21, 715-22.
27. Almutairi, A., Rossin, R., Shokeen, M., Hagooly, A., Ananth, A., Capoccia, B., Guillaudeu, S., Abendschein, D., Anderson, C. J., Welch, M. J., and Frechet, J. M. (2009) Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 106, 685-90.
28. Rossin, R., Muro, S., Welch, M. J., Muzykantov, V. R., and Schuster, D. P. (2008) In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J. Nucl. Med. 49, 103-11.
29. Liu, Y., Ibricevic, A., Cohen, J. A., Cohen, J. L., Gunsten, S. P., Frechet, J. M., Walter, M. J., Welch, M. J., and Brody, S. L. (2009) Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. Mol. Pharm. 6, 1891-902.
30. Tang, L. (2008) Radionuclide production and yields at Washington University School of Medicine. Q. J. Nucl. Med. Mol. Imaging 52, 121-33.
31. Hamoudeh, M., Kamleh, M. A., Diab, R., and Fessi, H. (2008) Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv. Drug Delivery Rev. 60, 1329-46.
32. Shokeen, M., Fettig, N. M., and Rossin, R. (2008) Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles. Q. J. Nucl. Med. Mol. Imaging 52, 267-77.
33. Kagadis, G. C., Loudos, G., Katsanos, K., Langer, S. G., and Nikiforidis, G. C. (2010) In vivo small animal imaging: current status and future prospects. Med. Phys. 37, 6421-42.
34. Anderson, C. J., and Ferdani, R. (2009) Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother. Radiopharm. 24, 379-93.
35. http://clinicaltrials.gov/ct2/results?term=dota.
36. Schipper, M. L., Iyer, G., Koh, A. L., Cheng, Z., Ebenstein, Y., Aharoni, A., Keren, S., Bentolila, L. A., Li, J., Rao, J., Chen, X., Banin, U., Wu, A. M., Sinclair, R., Weiss, S., and Gambhir, S. S. (2009) Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 5, 126-34.
37. Hardman, R. (2006) A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 114, 165-72.
38. McCarthy, J. R., and Weissleder, R. (2008) Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Delivery Rev. 60, 1241-51.
39. Heesakkers, R. A., Hovels, A. M., Jager, G. J., van den Bosch, H. C., Witjes, J. A., Raat, H. P., Severens, J. L., Adang, E. M., van der Kaa, C. H., Futterer, J. J., and Barentsz, J. (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol. 9, 850-6.
40. Yang, X., Hong, H., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Xiao, Y., Yang, Y., Zhang, Y., Nickles, R. J., Cai, W., Steeber, D. A., and Gong, S. (2011) cRGD-functionalized, DOX-conjugated, and (64)Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32, 4151-60.
41. Stelter, L., Pinkernelle, J. G., Michel, R., Schwartlander, R., Raschzok, N., Morgul, M. H., Koch, M., Denecke, T., Ruf, J., Baumler, H., Jordan, A., Hamm, B., Sauer, I. M., and Teichgraber, U. (2010) Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging. Mol. Imaging Biol. 12, 25-34.
42. Choi, J. S., Park, J. C., Nah, H., Woo, S., Oh, J., Kim, K. M., Cheon, G. J., Chang, Y., Yoo, J., and Cheon, J. (2008) A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. Angew. Chem., Int. Ed. Engl. 47, 6259-62.
43. Chen, J., Glaus, C., Laforest, R., Zhang, Q., Yang, M., Gidding, M., Welch, M. J., and Xia, Y. (2010) Gold nanocages as photothermal transducers for cancer treatment. Small 6, 811-7.
44. Xie, H., Wang, Z. J., Bao, A., Goins, B., and Phillips, W. T. (2010) In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. Int. J. Pharm. 395, 324-30.
45. Gregoriadis, G., and Ryman, B. E. (1971) Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem. J. 124, 58P.
46. Phillips, W. T., Goins, B. A., and Bao, A. (2009) Radioactive liposomes. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 69-83.
47. Bimbo, L. M., Sarparanta, M., Santos, H. A., Airaksinen, A. J., Makila, E., Laaksonen, T., Peltonen, L., Lehto, V. P., Hirvonen, J., and Salonen, J. (2010) Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 4, 3023-32.
48. Kumar, R., Roy, I., Ohulchanskky, T. Y., Vathy, L. A., Bergey, E. J., Sajjad, M., and Prasad, P. N. (2010) In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4, 699-708.
49. Martin, R., Menchon, C., Apostolova, N., Victor, V. M., Alvaro, M., Herance, J. R., and Garcia, H. (2010) Nano-jewels in biology. Gold and platinum on diamond nanoparticles as antioxidant systems against cellular oxidative stress. ACS Nano 4, 6957-65.
50. Liu, Q., Sun, Y., Li, C., Zhou, J., Li, C., Yang, T., Zhang, X., Yi, T., Wu, D., and Li, F. (2011) 18F-Labeled magnetic-upconversion nanophosphors via rare-Earth cation-assisted ligand assembly. ACS Nano 5, 3146-57.
51. Zhou, J., Yu, M., Sun, Y., Zhang, X., Zhu, X., Wu, Z., Wu, D., and Li, F. (2011) Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 32, 1148-56.
52. Sun, Y., Yu, M., Liang, S., Zhang, Y., Li, C., Mou, T., Yang, W., Zhang, X., Li, B., Huang, C., and Li, F. (2011) Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node. Biomaterials 32, 2999-3007.
53. Buxton, D. B. (2011) Nanotechnology research support at the national heart, lung, and blood institute. Circ. Res. 109, 250-4.
54. Sun, G., Hagooly, A., Xu, J., Nystrom, A. M., Li, Z., Rossin, R., Moore, D. A., Wooley, K. L., and Welch, M. J. (2008) Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles. Biomacromolecules 9, 1997-2006.
55. Nahrendorf, M., Sosnovik, D. E., French, B. A., Swirski, F. K., Bengel, F., Sadeghi, M. M., Lindner, J. R., Wu, J. C., Kraitchman, D. L., Fayad, Z. A., and Sinusas, A. J. (2009) Multimodality cardiovascular molecular imaging, Part II. Circ. Cardiovasc. Imaging 2, 56-70.
56. Sinusas, A. J., Bengel, F., Nahrendorf, M., Epstein, F. H., Wu, J. C., Villanueva, F. S., Fayad, Z. A., and Gropler, R. J. (2008) Multimodality cardiovascular molecular imaging, part I. Circ. Cardiovasc. Imaging 1, 244-56.
57. Nahrendorf, M., Zhang, H., Hembrador, S., Panizzi, P., Sosnovik, D. E., Aikawa, E., Libby, P., Swirski, F. K., and Weissleder, R. (2008) Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117, 379-87.
58. Buxton, D. B. (2009) Current status of nanotechnology approaches for cardiovascular disease: a personal perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 149-55.
59. Anderson, C. J., Bulte, J. W., Chen, K., Chen, X., Khaw, B. A., Shokeen, M., Wooley, K. L., and VanBrocklin, H. F. (2010) Design of targeted cardiovascular molecular imaging probes. J. Nucl. Med. 51 (Suppl 1), 3S-17S.
60. Gaucher, G., Dufresne, M. H., Sant, V. P., Kang, N., Maysinger, D., and Leroux, J. C. (2005) Block copolymer micelles: preparation, characterization and application in drug delivery. J. Controlled Release 109, 169-88. (Pubitemid 41742123)
61. Nishiyama, N., and Kataoka, K. (2006) Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 112, 630-48. (Pubitemid 44592613)
62. Xu, J., Sun, G., Rossin, R., Hagooly, A., Li, Z., Fukukawa, K. I., Messmore, B. W., Moore, D. A., Welch, M. J., Hawker, C. J., and Wooley, K. L. (2007) Labeling of polymer nanostructures for medical imaging: importance of crosslinking extent, spacer length, and charge density. Macromolecules 40, 2971-2973. (Pubitemid 46750589)
63. Sun, G., Xu, J., Hagooly, A., Rossin, R., Li, Z., Moore, D. A., Hawker, C. J., Welch, M. J., and Wooley, K. L. (2007) Strategies for optimized radiolabeling of nanoparticles for in vivo PET imaging. Adv. Mater. 19, 3157-3162. (Pubitemid 350044453)
64. Fukukawa, K., Rossin, R., Hagooly, A., Pressly, E. D., Hunt, J. N., Messmore, B. W., Wooley, K. L., Welch, M. J., and Hawker, C. J. (2008) Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications. Biomacromolecules 9, 1329-39. (Pubitemid 351639589)
65. Pressly, E. D., Rossin, R., Hagooly, A., Fukukawa, K., Messmore, B. W., Welch, M. J., Wooley, K. L., Lamm, M. S., Hule, R. A., Pochan, D. J., and Hawker, C. J. (2007) Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. Biomacromolecules 8, 3126-34. (Pubitemid 350011634)
66. Shokeen, M., Pressly, E. D., Hagooly, A., Zheleznyak, A., Ramos, N., Fiamengo, A. L., Welch, M. J., Hawker, C. J., and Anderson, C. J. (2011) Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. ACS Nano 5, 738-47.
67. Liu, Y., Pressly, E. D., Abendschein, D., Hawker, C. J., Woodard, G. E., Woodard, P. K., and Welch, M. J. (2011) Targeting angiogenesis using a C-type atrial natriuretic factor conjugated nanoprobe and positron emission tomography. J. Nucl. Med. 52, 1956-1963.
68. Kumari, A., Yadav, S. K., and Yadav, S. C. (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf., B: Biointerfaces 75, 1-18.
69. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., and Rudzinski, W. E. (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J. Controlled Release 70, 1-20. (Pubitemid 32144788)
70. Gan, C. W., Chien, S., and Feng, S. S. (2010) Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation. Curr. Pharm. Des. 16, 2308-20.
71. Courant, T., Roullin, V. G., Cadiou, C., Delavoie, F., Molinari, M., Andry, M. C., and Chuburu, F. (2009) Development and physicochemical characterization of copper complexes-loaded PLGA nanoparticles. Int. J. Pharm. 379, 226-34.
72. Devaraj, N. K., Keliher, E. J., Thurber, G. M., Nahrendorf, M., and Weissleder, R. (2009) 18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjugate Chem. 20, 397-401.
73. Nahrendorf, M., Keliher, E., Marinelli, B., Leuschner, F., Robbins, C. S., Gerszten, R. E., Pittet, M. J., Swirski, F. K., and Weissleder, R. (2011) Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomography. Arterioscler. Thromb. Vasc. Biol. 31, 750-7.
74. Swai, H., Semete, B., Kalombo, L., Chelule, P., Kisich, K., and Sievers, B. (2009) Nanomedicine for respiratory diseases. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 255-63.
75. Rytting, E., Nguyen, J., Wang, X., and Kissel, T. (2008) Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin. Drug Delivery 5, 629-39. (Pubitemid 351998253)
76. Roy, I., and Vij, N. (2010) Nanodelivery in airway diseases: challenges and therapeutic applications. Nanomedicine 6, 237-44.
77. Roller, J., Laschke, M.W., Tschernig, T., Schramm, R., Veith, N. T., Thorlacius, H., and Menger, M. D. (2011) How to detect a dwarf: in vivo imaging of nanoparticles in the lung. Nanomedicine 7, 753-62.
78. Card, J. W., Zeldin, D. C., Bonner, J. C., and Nestmann, E. R. (2008) Pulmonary applications and toxicity of engineered nanoparticles. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L400-11.
79. Semete, B., Booysen, L. I., Kalombo, L., Venter, J. D., Katata, L., Ramalapa, B., Verschoor, J. A., and Swai, H. (2010) In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. Toxicol. Appl. Pharmacol. 249, 158-65.
80. Semete, B., Booysen, L., Lemmer, Y., Kalombo, L., Katata, L., Verschoor, J., and Swai, H. S. (2010) In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine 6, 662-71.
81. Murthy, N., Xu, M., Schuck, S., Kunisawa, J., Shastri, N., and Frechet, J. M. (2003) A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Proc. Natl. Acad. Sci. U. S. A. 100, 4995-5000. (Pubitemid 36542647)
82. Murthy, N., Thng, Y. X., Schuck, S., Xu, M. C., and Frechet, J. M. (2002) A novel strategy for encapsulation and release of proteins: hydrogels and microgels with acid-labile acetal cross-linkers. J. Am. Chem. Soc. 124, 12398-9. (Pubitemid 35204550)
83. Standley, S. M., Kwon, Y. J., Murthy, N., Kunisawa, J., Shastri, N., Guillaudeu, S. J., Lau, L., and Frechet, J. M. (2004) Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model. Bioconjugate Chem. 15, 1281-8. (Pubitemid 39552017)
84. Lundberg, P., and Langel, U. (2003) A brief introduction to cell-penetrating peptides. J. Mol. Recognit. 16, 227-33. (Pubitemid 37231690)
85. Shoyele, S. A., and Cawthorne, S. (2006) Particle engineering techniques for inhaled biopharmaceuticals. Adv. Drug Delivery Rev. 58, 1009-29. (Pubitemid 44712022)
86. Cohen, J. L., Almutairi, A., Cohen, J. A., Bernstein, M., Brody, S. L., Schuster, D. P., and Frechet, J. M. (2008) Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides. Bioconjugate Chem. 19, 876-81. (Pubitemid 351614543)
87. Rojas, S., Gispert, J. D., Martin, R., Abad, S., Menchon, C., Pareto, D., Victor, V. M., Alvaro, M., Garcia, H., and Herance, J. R. (2011) Biodistribution of amino-functionalized diamond nanoparticles. In vivo studies based on 18F radionuclide emission. ACS Nano 5, 5552-9.
88. Hofman, M. S., Beauregard, J. M., Barber, T. W., Neels, O. C., Eu, P., and Hicks, R. J. (2011) 68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphy. J. Nucl. Med. 52, 1513-9.
89. Strebhardt, K., and Ullrich, A. (2008) Paul Ehrlich's magic bullet concept: 100 years of progress. Nat. Rev. Cancer 8, 473-80. (Pubitemid 351752547)
90. Ting, G., Chang, C. H., and Wang, H. E. (2009) Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy. Anticancer Res. 29, 4107-18.
91. Ting, G., Chang, C. H., Wang, H. E., and Lee, T. W. (2010) Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J. Biomed. Biotechnol., 2010.
92. Pirollo, K. F., and Chang, E. H. (2008) Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol. 26, 552-8.
93. Fang, J., Nakamura, H., and Maeda, H. (2011) The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Delivery Rev. 63, 136-51.
94. Jiang, W., Kim, B. Y., Rutka, J. T., and Chan, W. C. (2008) Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 3, 145-50. (Pubitemid 351355131)
95. Adair, J. H., Parette, M. P., Altinoglu, E. I., and Kester, M. (2010) Nanoparticulate alternatives for drug delivery. ACS Nano 4, 4967-70.
96. Minelli, C., Lowe, S. B., and Stevens, M. M. (2010) Engineering nanocomposite materials for cancer therapy. Small 6, 2336-57.
97. Hallaj-Nezhadi, S., Lotfipour, F., and Dass, C. R. (2010) Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy. Pharmazie 65, 855-9.
98. Alexis, F., Pridgen, E. M., Langer, R., and Farokhzad, O. C. (2010) Nanoparticle technologies for cancer therapy. Handb. Exp. Pharmacol., 55-86.
99. Pridgen, E. M., Langer, R., and Farokhzad, O. C. (2007) Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine (Lond.) 2, 669-80. (Pubitemid 350268246)
100. Younes, C. K., Boisgard, R., and Tavitian, B. (2002) Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. Curr. Pharm. Des. 8, 1451-66. (Pubitemid 34693063)
101. Sun, X., Fang, H., Li, X., Rossin, R., Welch, M. J., and Taylor, J. S. (2005) MicroPET imaging of MCF-7 tumors in mice via unr mRNA-targeted peptide nucleic acids. Bioconjugate Chem. 16, 294-305. (Pubitemid 40388204)
102. Rossin, R., Sun, X., Fang, H., Turner, J. L., Li, X., Wooley, K. L., Taylor, J. S., Welch, M. J. (2005) in Journal of Labelled Compounds and Radiopharmaceuticals, p S35, Wiley, Iowa City.
103. Rossin, R., Pan, D., Qi, K., Turner, J. L., Sun, X., Wooley, K. L., and Welch, M. J. (2005) 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J. Nucl. Med. 46, 1210-8. (Pubitemid 43741084)
104. Zhou, D., Zeng, D., Lee, N., Dence, C., Wooley, K., Katzenellenbogen, J., and Welch, M. (2011) Fluorine-18 radiolabeling of SCK nanoparticles via copper-free click chemistry. J. Nucl. Med. Meeting Abstracts 52, 569.
105. Zeng, D., Lee, N., Liu, Y., Zhou, D., Dence, C., Wooley, K., Katzenellenbogen, J., and Welch, M. (2011) Novel strategy for preparing Cu-64 nanoparticles with ultrahigh specific activity using metal-free click chemistry. J. Nucl. Med. Meeting Abstracts 52, 576.
106. Xie, J., Chen, K., Huang, J., Lee, S., Wang, J., Gao, J., Li, X., and Chen, X. (2010) PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31, 3016-22.
107. Torres Martin de Rosales, R., Tavare, R., Paul, R. L., Jauregui-Osoro, M., Protti, A., Glaria, A., Varma, G., Szanda, I., and Blower, P. J. (2011) Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agent. Angew. Chem., Int. Ed. Engl. 50, 5509-13.
108. Jarrett, B. R., Gustafsson, B., Kukis, D. L., and Louie, A. Y. (2008) Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjugate Chem. 19, 1496-504. (Pubitemid 352032352)
109. Tabatabai, G., Tonn, J. C., Stupp, R., Weller, M. (2011) The role of integrins in glioma biology and anti-glioma therapies. Curr. Pharm. Des.
110. Beer, A. J., Kessler, H., Wester, H. J., and Schwaiger, M. (2011) PET Imaging of Integrin alphaVbeta3 Expression. Theranostics 1, 48-57.
111. Ruggiero, A., Holland, J. P., Lewis, J. S., and Grimm, J. (2010) Cerenkov luminescence imaging of medical isotopes. J. Nucl. Med. 51, 1123-30.
112. Park, J. C., Yu, M. K., An, G. I., Park, S. I., Oh, J., Kim, H. J., Kim, J. H., Wang, E. K., Hong, I. H., Ha, Y. S., Choi, T. H., Jeong, K. S., Chang, Y., Welch, M. J., Jon, S., and Yoo, J. (2010) Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. Small 6, 2863-8.
113. Xie, H., Diagaradjane, P., Deorukhkar, A. A., Goins, B., Bao, A., Phillips, W. T., Wang, Z., Schwartz, J., and Krishnan, S. (2011) Integrin alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy. Int. J. Nanomed. 6, 259-69.
114. Zhou, M., Zhang, R., Huang, M., Lu, W., Song, S., Melancon, M. P., Tian, M., Liang, D., and Li, C. (2010) A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J. Am. Chem. Soc. 132, 15351-8.
115. Lammers, T., Kiessling, F., Hennink, W. E., and Storm, G. (2010) Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol. Pharm. 7, 1899-912.
116. Kelkar, S. S., and Reineke, T. M. (2011) Theranostics: combining imaging and therapy. Bioconjugate Chem. 22, 1879-903.
117. Petersen, A. L., Binderup, T., Rasmussen, P., Henriksen, J. R., Elema, D. R., Kjaer, A., and Andresen, T. L. (2011) 64Cu loaded liposomes as positron emission tomography imaging agents. Biomaterials 32, 2334-41.
118. Rygh, C. B., Qin, S., Seo, J. W., Mahakian, L. M., Zhang, H., Adamson, R., Chen, J. Q., Borowsky, A. D., Cardiff, R. D., Reed, R. K., Curry, F. R., and Ferrara, K. W. (2010) Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET. Clin. Cancer Res. 17, 550-9.
119. Medina, O. P., Pillarsetty, N., Glekas, A., Punzalan, B., Longo, V., Gonen, M., Zanzonico, P., Smith-Jones, P., and Larson, S. M. (2011) Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system. J. Controlled Release 149, 292-8.
120. Holland, J. P., Sheh, Y., and Lewis, J. S. (2009) Standardized methods for the production of high specific-activity zirconium-89. Nucl. Med. Biol. 36, 729-39.
121. Keliher, E. J., Yoo, J., Nahrendorf, M., Lewis, J. S., Marinelli, B., Newton, A., Pittet, M. J., and Weissleder, R. (2011) (89)Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. Bioconjugate Chem. 22, 2383-9.
122. Duconge, F., Pons, T., Pestourie, C., Herin, L., Theze, B., Gombert, K., Mahler, B., Hinnen, F., Kuhnast, B., Dolle, F., Dubertret, B., and Tavitian, B. (2008) Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales. Bioconjugate Chem. 19, 1921-6.
123. Tu, C., Ma, X., House, A., Kauzlarich, S. M., and Louie, A. Y. (2011) PET imaging and biodistribution of silicon quantum dots in mice. ACS Med. Chem. Lett. 2, 285-288.
124. Hwang, D., Ko, H., Kim, S.-K., Kim, D., Lee, D., and Kim, S. (2009) Development of a quadruple imaging modality by using nanoparticles. Chem. - Eur. J. 15, 9387-9393.
125. Jauregui-Osoro, M., Williamson, P. A., Glaria, A., Sunassee, K., Charoenphun, P., Green, M. A., Mullen, G. E., and Blower, P. J. (2011) Biocompatible inorganic nanoparticles for [(18)F]-fluoride binding with applications in PET imaging. Dalton Trans,.
126. Liu, Q., Sun, Y., Li, C., Zhou, J., Yang, T., Zhang, X., Yi, T., Wu, D., and Li, F. (2011) (18)F-labeled magnetic-upconversion nanophosphors via rare-earth cation-assisted ligand assembly. ACS Nano 5, 3146-57.
127. Cartier, R., Kaufner, L., Paulke, B. R., Wustneck, R., Pietschmann, S., Michel, R., Bruhn, H., and Pison, U. (2007) Latex nanoparticles for multimodal imaging and detection in vivo. Nanotechnology 18, 195102.
128. Seo, J. W., Mahakian, L. M., Kheirolomoom, A., Zhang, H., Meares, C. F., Ferdani, R., Anderson, C. J., and Ferrara, K. W. (2010) Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects. Bioconjugate Chem. 21, 1206-15.
129. Seo, J. W., Zhang, H., Kukis, D. L., Meares, C. F., and Ferrara, K. W. (2008) A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging. Bioconjugate Chem. 19, 2577-84.
130. Oku, N., Yamashita, M., Katayama, Y., Urakami, T., Hatanaka, K., Shimizu, K., Asai, T., Tsukada, H., Akai, S., and Kanazawa, H. (2011) PET imaging of brain cancer with positron emitter-labeled liposomes. Int. J. Pharm. 403, 170-7.
131. Marik, J., Tartis, M. S., Zhang, H., Fung, J. Y., Kheirolomoom, A., Sutcliffe, J. L., and Ferrara, K. W. (2007) Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). Nucl. Med. Biol. 34, 165-71. (Pubitemid 46241896)
132. Helbok, A., Decristoforo, C., Dobrozemsky, G., Rangger, C., Diederen, E., Stark, B., Prassl, R., and von Guggenberg, E. (2009) Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals. J. Liposome Res. 20, 219-27.
133. Andreozzi, E., Seo, J. W., Ferrara, K., and Louie, A. (2011) Novel method to label solid lipid nanoparticles with (64)cu for positron emission tomography imaging. Bioconjugate Chem. 22, 808-18.
134. Herth, M. M., Barz, M., Moderegger, D., Allmeroth, M., Jahn, M., Thews, O., Zentel, R., and Rosch, F. (2009) Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography. Biomacromolecules 10, 1697-703.
135. Ruggiero, A., Villa, C. H., Holland, J. P., Sprinkle, S. R., May, C., Lewis, J. S., Scheinberg, D. A., and McDevitt, M. R. (2010) Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes. Int. J. Nanomed. 5, 783-802.